Legacy Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Sell
5,014
-351
-7% -$28.3K 0.28% 34
2026
Q1
$465K Sell
5,365
-651
-11% -$62.4K 0.35% 29
2025
Q4
$578K Hold
6,016
0.43% 27
2025
Q3
$573K Hold
6,016
0.43% 27
2025
Q2
$524K Hold
6,016
0.42% 28
2025
Q1
$541K Buy
6,016
+1,432
+31% +$128K 0.46% 23
2024
Q4
$366K Sell
4,584
-1
-0% -$87 0.31% 42
2024
Q3
$413K Hold
4,585
0.35% 38
2024
Q2
$361K Hold
4,585
0.33% 39
2024
Q1
$400K Sell
4,585
-76
-2% -$6.49K 0.38% 39
2023
Q4
$384K Buy
+4,661
New +$355K 0.41% 35

Other funds holding MDT

Legacy Advisory Services's MDT Position: Q2 2026 in Review

Legacy Advisory Services reduced its Medtronic (MDT) stake by 6.5% in Q2 2026, selling an estimated $28.3K and leaving 5,014 shares worth $392K. The position accounts for 0.28% of the portfolio, ranked #34.

Legacy Advisory Services first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $578K in Q4 2025. 662 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Legacy Advisory Services held 5,014 shares of Medtronic worth $392K as of Q2 2026.
  • Legacy Advisory Services sold 351 Medtronic shares in Q2 2026, an estimated $28.3K.
  • Medtronic made up 0.28% of Legacy Advisory Services's portfolio in Q2 2026, its #34 holding.
  • Legacy Advisory Services first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Legacy Advisory Services's Medtronic position peaked at $578K in Q4 2025.
  • 662 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Legacy Advisory Services's 13F filing for Q2 2026, filed 21 Jul 2026.